Found 316 results for recognition-award

Custom crystal commemorating an exclusive distribution agreement between California-based pharmaceutical firm Zogenix and Japanese pharma company Nippon Shinyaku.

Custom crystal celebrating a commercial rights agreement between pharmaceutical firm Zogenix and Nippon Shinyaku. Zogenix focuses on rare disease therapies.

Pill-themed crystal deal toy commemorating a license agreement between Asahi Kasei Pharma Corporation, headquartered in Tokyo, and New York-based Woolsey Pharmaceuticals.

Lucite tombstone commemorating a joint venture between pharmaceutical firms Pfizer and GlaxoSmithKline. The joint venture centers on the over-the-counter consumer healthcare business.

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.

Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.

Crystal tombstone commemorating an exclusive licensing agreement between Ovid Therapuetics and Angelini Pharma. The agreement centers on the development, manufacturing, and commercialization of a potential treatment for Angelman syndrome.

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

Custom crystal commemorative celebrating the launch of Wynzora Cream, a topical treatment for plaque psoriasis that received approval from the FDA (Food and Drug Administration) in 2020. The product launch resulted from a collaboration agreement between Denmark-based MC2 Therapeutics, and EPI Health, a specialty pharmaceutical firm headquartered in Charleston, South Carolina.